Cartesian Therapeutics, Inc.
RNAC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001453687
No open-market purchases or sales by Cartesian Therapeutics, Inc. insiders were filed in the last 90 days; 94 institutions reported holding it in 13F filings for Q2 2026, worth $90.4M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Cartesian Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 103
- +2 vs. Q2 2021
- Shares held
- 51.9M
- −513.4K (−1.0%) vs. Q2 2021
- Total value
- $216.7M
- −$2.46M (−1.1%) vs. Q2 2021
- New holders
- 16
- 36 more added
- Sold out
- 14
- 31 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RNAC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 94 | $90.4M |
| Q1 2026 | 83 | $43.9M |
| Q4 2025 | 67 | $37.2M |
| Q3 2025 | 68 | $60.9M |
| Q2 2025 | 66 | $66.5M |
| Q1 2025 | 72 | $86.7M |
| Q4 2024 | 68 | $119.5M |
| Q3 2024 | 64 | $110.3M |
| Q2 2024 | 62 | $88.3M |
| Q1 2024 | 70 | $35.3M |
| Q4 2023 | 80 | $37.8M |
| Q3 2023 | 87 | $57.2M |
| Q2 2023 | 92 | $63.2M |
| Q1 2023 | 95 | $65.1M |
| Q4 2022 | 86 | $62.8M |
| Q3 2022 | 97 | $104.9M |
| Q2 2022 | 93 | $79.3M |
| Q1 2022 | 102 | $71.6M |
| Q4 2021 | 106 | $185.7M |
| Q3 2021 | 103 | $216.7M |
| Q2 2021 | 101 | $219.2M |
| Q1 2021 | 98 | $245.1M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Cartesian Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| State Street Corp | 4,429,988 | $18.4M | 0.00% | +3,017,394+213.6% | Added |
| Vanguard Group Inc | 5,063,997 | $21.1M | 0.00% | +29,196+0.6% | Added |
| BlackRock Inc. | 6,965,596 | $29.0M | 0.00% | +274,607+4.1% | Added |
| Cetera Advisors LLC | 0 | $0 | 0.00% | −1,106,325−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −304,297−100.0% | Sold out |
| TT International Asset Management LTD | 0 | $0 | 0.00% | −140,000−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −83,201−100.0% | Sold out |
| Banque Cantonale Vaudoise | 0 | $0 | 0.00% | −73,000−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −41,155−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −31,903−100.0% | Sold out |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −25,500−100.0% | Sold out |
| Hancock Whitney Corp | 0 | $0 | 0.00% | −24,917−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −12,492−100.0% | Sold out |
| Raymond James Financial Services Advisors, Inc. | 0 | $0 | 0.00% | −12,297−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −11,717−100.0% | Sold out |
| Edmond de Rothschild Holding S.A. | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −1,442−100.0% | Sold out |